Simo Huang

Dr. Simo Huang

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2021 in Medicina
Verified
Journal Article
Open access
PDF file
RFRobert Frantz
Robert Frantz
SHSimo Huang
Simo Huang
AAAbhirup Are
Abhirup Are
KMKiran Motaparthi
Kiran Motaparthi
Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare diseases that are characterized by widespread epidermal necrosis and sloughing of skin. They are associated with significant morbidity and mortality, and early diagnosis and treatment is critical in achieving favorable outcomes for patients. In this scoping review, Excerpta Medica dataBASE and PubMed were searched for publications that addressed recent advances in the diagnosis and management of the disease. Multiple proteins (galectin 7 and RIP3) were identified that are promising potential biomarkers for SJS/TEN, although both are still in early phases of research. Regarding treatment, cyclosporine is the most effective therapy for the treatment of SJS, and a combination of intravenous immunoglobulin (IVIg) and corticosteroids is most effective for SJS/TEN overlap and TEN. Due to the rare nature of the disease, there is a lack of prospective, randomized controlled trials and conducting these in the future would provide valuable insights into the management of this disease.

9 October 2021 in Medicina
Verified
Journal Article
Open access
PDF file
AMAli M. Malik
Ali M. Malik
STSarah Anne Tupchong
Sarah Anne Tupchong
SHSimo Huang
Simo Huang
AAAbhirup Are
Abhirup Are
SHSylvia Hsu
Sylvia Hsu
KMKiran Motaparthi
Kiran Motaparthi
Clinicians may encounter a variety of skin conditions that present with vesiculobullous lesions in their everyday practice. Pemphigus vulgaris, pemphigus foliaceus, IgA pemphigus, and paraneoplastic pemphigus represent the spectrum of autoimmune bullous dermatoses of the pemphigus family. The pemphigus family of diseases is characterized by significant morbidity and mortality. Considering the risks associated with a delayed diagnosis or misdiagnosis and the potential for overlap in clinical features and treatment, evaluation for suspected pemphigus disease often requires thorough clinical assessment and laboratory testing. Diagnosis is focused on individual biopsies for histopathology and direct immunofluorescence. Additional laboratory methods used for diagnosis include indirect immunofluorescence and enzyme-linked immunosorbent assay. Recent advancements, including anti-CD20 therapy, have improved the efficacy and reduced the morbidity of pemphigus treatment. This contribution presents updates on the pathophysiology, clinical features, diagnostic work-up, and medical management of pemphigus. Improved strategies for diagnosis and clinical assessment are reviewed, and newer treatment options are discussed.

29 August 2018 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
SHSimo Huang
Simo Huang
JWJulie H. Wu
Julie H. Wu
DLDaniel J. Lewis
Daniel J. Lewis
PRPeter L. Rady
Peter L. Rady
STStephen Tyring
Stephen Tyring

4 October 2021 in Medicina
Verified
Journal Article
Open access
PDF file
Valeryia PratasavaValeryia Pratasava
Valeryia Pratasava
VSVikram N. Sahni
Vikram N. Sahni
ASAishwarya Suresh
Aishwarya Suresh
SHSimo Huang
Simo Huang
AAAbhirup Are
Abhirup Are
KMKiran Motaparthi
Kiran Motaparthi
The pemphigoid family of dermatoses is characterized by autoimmune subepidermal blistering. The classic paradigm for pemphigoid, and the most common member, is bullous pemphigoid. Its variable clinical presentation, with or without frank bullae, is linked by significant pruritus afflicting the elderly. Mucous membrane pemphigoid is an umbrella term for a group of subepidermal blistering dermatoses that favor the mucosal membranes and can scar. Epidermolysis bullosa acquisita is a chronic blistering disorder characterized by skin fragility, sensitivity to trauma, and its treatment-refractory nature. Clinicians that encounter these pemphigoid disorders may benefit from an overview of their clinical presentation, diagnostic work-up, and therapeutic management, with an emphasis on the most frequently encountered pemphigoid disease, bullous pemphigoid.

14 March 2021 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
SSSteven A. Svoboda
Steven A. Svoboda
SHSimo Huang
Simo Huang
XLXinyang Liu
Xinyang Liu
SHSylvia Hsu
Sylvia Hsu
KMKiran Motaparthi
Kiran Motaparthi

23 September 2021 in Medicina
Verified
Journal Article
Open access
PDF file
MSMorgan Sussman
Morgan Sussman
ANAnthony Napodano
Anthony Napodano
SHSimo Huang
Simo Huang
AAAbhirup Are
Abhirup Are
SHSylvia Hsu
Sylvia Hsu
KMKiran Motaparthi
Kiran Motaparthi
The similarity between pustular psoriasis (PP) and acute generalized exanthematous pustulosis (AGEP) poses problems in the diagnosis and treatment of these two conditions. Significant clinical and histopathologic overlap exists between PP and AGEP. PP is an inflammatory disorder that has numerous clinical subtypes, but all with sterile pustules composed of neutrophils. AGEP is a severe cutaneous adverse reaction that is also characterized by non-follicular sterile pustules. Clinical features that suggest a diagnosis of PP over AGEP include a history of psoriasis and the presence of scaling plaques. Histologically, eosinophilic spongiosis, vacuolar interface dermatitis, and dermal eosinophilia favor a diagnosis of AGEP over PP. Importantly, PP and AGEP vary in clinical course and treatment. PP treatment involves topical steroids, oral retinoids, and systemic immunosuppressants. Newer therapies targeting IL-36, IL-23, IL-1, and PDE-4 have been investigated. The removal of the offending agent is a crucial part of the treatment of AGEP.